Table 2. Multivariate logistic regression analysis between MHR and hemorrhagic transformation.

	unadjusted		Model 1		Model 2
	OR (95% CI)	P-value	OR (95% CI)	P-value	OR (95% CI)	P-value
MHR (Per 1 SD increase)	0.24 (0.08-0.71)	0.010	0.26 (0.08 - 0.91)	0.034	0.22 (0.06 - 0.78)	0.020
Tertiles of MHR
Tertile 1 (< 0.22)	1.85 (1.21 - 2.82)	0.004	1.75 (1.06 - 2.89)	0.029	1.81 (1.08 - 3.01)	0.024
Tertile 2 (0.22 - 0.37)	0.98 (0.62 - 1.54)	0.919	0.92 (0.55 - 1.53)	0.755	0.85 (0.50 - 1.44)	0.547
Tertile 3 (> 0.37)	1		1		1

Model 1: adjusted for age, sex, atrial fibrillation, drinking, National Institutes of Health Stroke Scale, systolic blood pressure, white blood cell, low-density lipoprotein cholesterol and large infarct size; Model 2: adjusted for covariates from Model 1 and further adjusted for antiplatelets, thrombolysis, thrombectomy, lipid-lowering agents after admission and the Trial of ORG 10172 in Acute Stroke Treatment classification. MHR, monocyte to high-density lipoprotein cholesterol ratio.